baber/WOPTO huggingface dataset:
Patent DK-2316924-T3 (DK)
Inventor: GARCIA-SASTRE ADOLFO
IPC: C12N7/00
Filed: 1999-06-11
Granted: 2018-01-02
Abstract: The present invention relates, in general, to attenuated negative-strand RNA viruses having an impaired ability to antagonize the cellular interferon (IFN) response, and the use of such attenuated viruses in vaccine and pharmaceutical formulations. The invention also relates to the development and use of IFN-deficient systems for selection of such attenuated viruses. In particular, the invention relates to attenuated influenza viruses having modifications to the NS1 gene that diminish or eliminate the ability of the NS1 gene product to antagonize the cellular IFN response. The mutant viruses replicate in vivo but demonstrate reduced pathogenicity, and therefore are well suited for live virus vaccines, and pharmaceutical formulations.
Patent DK-2906049-T3 (DK)
Inventor: CAPPELLE PHILIPPE JACQUES MYRIAM
IPC: A23K20/26
Filed: 2013-09-18
Granted: 2018-01-15
Abstract: The present invention relates to an inorganic solid nutritive composition comprising at least one polyphosphate and at least one source of iron as micronutrient, wherein said composition is water-soluble and comprises an iron content of between 0.1% and 5% by weight of iron relative to the total weight of said solid composition.
Patent DK-2940138-T3 (DK)
Inventor: DELAROQUE NICOLAS
IPC: C12N15/10
Filed: 2014-04-30
Granted: 2018-06-06
Abstract: A library of replicating entities, each entity comprises a recombinant vector comprising a randomized nucleic acid sequence, having the reading frame structure [NXX]n [CorAA] [NXX]m [NZZ]o, or [NZZ]o [NXX]m [CorAA] [NXX]n. Each NXX is independently a codon encoding for any amino acid except cysteine, CorAA is a codon encoding for cysteine or at least one other amino acid, each NZZ is independently a codon encoding for any amino acid, and n is an integer from 0 to 40, m is an integer from 1 to 20, o is an integer from 1 to 40, and at least 20 percent of CorAA encode for cysteine. The invention further relates to a set of recombinant vectors and to a set of randomized oligonucleotides, each oligonucleotide having said structure, as well as to a method for generating a library of replicating entities and to a method for identifying an amino acid polymer.
Patent DK-0393470-T3 (DK)
Inventor: ZIERHUT HERMANN DIPL-ING
IPC: H04B14/02
Filed: 1990-04-09
Granted: 1995-07-10
Abstract: A transmission link for transmitting a sequence of signals comprising pulse and interval signals, across a transmission medium from a transmitter to a receiver circuit of a receiver, whereby each pulse signal is modulated with a frequency. At least two frequencies are used to modulate the pulses, and a separate evaluation circuit is provided in the receiver for each modulating frequency. The output signals of the evaluation circuits are concatenated (linked in series) by a AND-gate circuit.
Patent DK-0403150-T3 (DK)
Inventor: URBAN FRANK JOHN
IPC: C07H15/04
Filed: 1990-06-06
Granted: 1995-01-16
Abstract: Improved processes for the synthesis of tigogenin beta-cellobioside, a known hypocholesterolemic agent, using cellobiose heptaacetate and tigogenin as starting materials, and novel intermediates useful in this process.
Patent DK-0491835-T3 (DK)
Inventor: THOLERUS JAN
IPC: B42C9/00
Filed: 1990-09-14
Granted: 1994-04-18
Abstract: The invention relates to a method for binding sheaves of papers into covers such as to form booklets, each booklet comprising a cover made up of two cover sheets, a spine therebetween, and a binding agent attached to the inside of the spine, as well as a sheaf of papers inserted in the cover, one side edge of the sheaf being connected to the inside of the spine. The binding takes place by means of the binding agent being activated by an activation device such that the edge of the sheaf of papers will be connected to the inside of the spine via the binding agent. Each cover acts on a sensing means, which senses the presence or non-presence of indication means connected to the cover and which actuates means for influencing the further course of the method. The invention also relates to a cover provided with indication means sensed in the above described manner.
Patent DK-0463513-T3 (DK)
Inventor: SAUTER HUBERT DR
IPC: C07C255/62
Filed: 1991-06-14
Granted: 1995-06-26
Abstract: Benzyl ketones of the formula  <IMAGE>  where X is CH or N, Y is O or NR4, R1, R2 are H or alkyl, R3 is halogen, cyano, nitro, alkyl, cycloalkyl, alkoxy, haloalkyl, arylalkyl, arylalkoxy, aryloxy or aryl, and the aryl groups in turn may be substituted, R4 is OH, alkoxy or arylalkoxy and R5 is H, methyl, halogen or methoxy, and fungicides containing these compounds.
Patent DK-0472934-T3 (DK)
Inventor: MUELLER GOTTFRIED
IPC: F24F13/06
Filed: 1991-07-30
Granted: 1994-03-14
Abstract: In a ceiling air outlet with outlet slots (4) and air-deflection slats (10) for blowing in supply air from an air-guidance system into a room, bearings (8) for holding slats (10) are to be bent off from a metal sheet (R), a steel plate or a plate of another material. 
<IMAGE>
Patent DK-0443918-T3 (DK)
Inventor: CLEMENCE FRANCOIS
IPC: A61P25/28
Filed: 1991-02-14
Granted: 1996-07-29
Abstract: New 20,21-dinoreburnamenine derivatives substituted in positions 9,10 and/or 11, process for their preparation and new intermediates thus obtained. These products have advantageous pharmacological properties which justify their use as medications.
Patent DK-0515541-T3 (DK)
Inventor: DUCHESNE JEAN-PIERRE
IPC: C07D305/14
Filed: 1991-02-20
Granted: 1994-06-13
Abstract: PCT No. PCT/FR91/00133 Sec. 371 Date Aug. 21, 1992 Sec. 102(e) Date Aug. 21, 1992 PCT Filed Feb. 20, 1991 PCT Pub. No. WO91/13066 PCT Pub. Date Sep. 5, 1991.A method for preparing  beta -phenylglycidic-(2R, 3R) acid optionally in the form of salt or ester by precipitation of the salt of the  beta -phenylglycidic-(2R,3R) acid with (+)- alpha -methylbenzylamine-(R) in a solution of a mixture of salts of cis and trans  beta -phenylglycidic acids with (+)- alpha -methylbenzylamine(R)- and the use of the resulting product for preparing taxol and its analogs.
Patent DK-0540526-T3 (DK)
Inventor: LOWE JOHN A III
IPC: A61K31/54
Filed: 1991-05-14
Granted: 1995-04-18
Abstract: Quinuclidine derivatives of the formula    <IMAGE>maceutically acceptable salts thereof, wherein m, P, Z, Y, R1, R2 and R3 are as defined below. The compounds are substance P antagonists and, therefore, are useful in treating gastrointestinal disorders, central nervous system disorders, inflammatory diseases, pain and migraine.
Patent DK-0495056-T3 (DK)
Inventor: BAHR KARL-HEINZ
IPC: B29C48/08
Filed: 1991-07-31
Granted: 1996-01-29
Abstract: PCT No. PCT/GB91/01297 Sec. 371 Date May 18, 1992 Sec. 102(e) Date May 18, 1992 PCT Filed Jul. 31, 1991 PCT Pub. No. WO92/02559 PCT Pub. Date Feb. 20, 1992.In a process for extruding or injection moulding starch-containing composition, a substantially transparent product is produced by providing that the starch used contains less than 8% by weight of water, that the water content of the starch in the barrel of the extruder or injection moulding machine is controlled so as to be within the range of from 5 to 20% by weight (based on the weight of the starch) and that water is removed from the composition immediately before the composition leaves the barrel of the extruder or the injection moulding machine so that the water content of the composition passing through the die and/or entering the mould is less than 3% by weight of the starch.
Patent DK-0547293-T3 (DK)
Inventor: SCHULTE-FRANKENFELD MANFRED
IPC: A01M21/04
Filed: 1992-08-10
Granted: 1995-12-18
Abstract: Such an apparatus has a heating element (2) arranged in an angled manner for hand guidance at the lower end of a shaft (9) and radiating downwards, this heating element being arranged in a housing (1) which is correspondingly open at the bottom. In order to be able to operate such an apparatus electrically, its heating element is an electrical tubular radiator (2) which is of self-supporting design and on which the housing is placed. The tubular radiator is arranged in the housing with coils (4) lying substantially in a plane parallel to the underside of the housing, and its two end sections (6, 7) are guided out of the housing and, forming a curve corresponding to the angling towards the shaft, are introduced into a coupling piece (8) seated on the shaft. <IMAGE>
Patent DK-0504981-T3 (DK)
Inventor: MARCHIONNA MARIO
IPC: C07C29/154
Filed: 1992-03-11
Granted: 1995-05-01
Abstract: A catalyst system for the liquid-phase production of methanol from synthesis gas is described, consisting of:     one or more copper compounds; one or more alkoxides of the lanthanum group of formula (R1O)xW and/or one or more inorganic oxides of the lanthanum and/or aluminium group; one or more alkaline and/or alkaline-earth alkoxides of formula (RaO)xM, if at least one alkoxide of the lanthanum group is present, then one or more alkoxides of the titanium group of formula (RtO)xT, where R1, Ra and Rt, which can be the same or different, are C1-C10 alkyl groups,  M is the alkaline or alkaline-earth metal,  W is an element of the lanthanum group,  T is an element of the titanium group, x is equal to the valency of the metal or element.
Patent DK-0533344-T3 (DK)
Inventor: OHNMACHT CYRUS JOHN
IPC: C07D417/04
Filed: 1992-08-11
Granted: 1997-03-03
Abstract: Compounds of formula I, and pharmaceutically acceptable salts thereof, useful in the treatment of neuropsychiatric disorders such as psychoses; pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable diluent or carrier; and methods of treating neuropschiatric disorders comprising administering to a mammal (including man) in need of such treatment an effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof. <IMAGE>
Patent DK-0562439-T3 (DK)
Inventor: MIYAKE AKIO
IPC: C07D/
Filed: 1993-03-17
Granted: 1999-11-15
Abstract: Novel compound represented by the formula: <CHEM> wherein R<1> stands for H, an optionally substituted lower alkyl group or a halogen; R<2> and R<3> respectively stands for a hydrogen or an optionally substituted lower alkyl group, or R<2> and R<3> may, taken together with the adjacent -C=C- group, form a 5- to 7-membered ring; X stands for O, SO or SO2; Y stands for a group of the formula:   <CHEM> (R<4> and R<5> respectively stand for H or an optionally substituted lower alkyl group) or a divalent group derived from an optionally substituted 3- to 7-membered homocyclic or heterocyclic ring; R<6> and R<7> each stands for H, an optionally substituted lower alkyl group, an optionally substituted cycloalkyl group or an optionally substituted aryl group, or R<6> and R<7> may, taken together with the adjacent N, form an optionally substituted N-containing heterocyclic group; m stands for 0 to 4; n stands for 0 to 4, or a salt thereof, which has excellent anti-PAF activities anti-LTC4 activities and anti-ET-1 activities, and is of value as an antiasthmatic agent, and their production, intermediates and pharmasceutical compositions.
Patent DK-0590271-T3 (DK)
Inventor: QUADRI LUISA
IPC: A61P9/00
Filed: 1993-08-03
Granted: 1996-12-16
Abstract: 17-Aryl and heterocyclyl-5 alpha ,14 beta -androstane and androstene and androstadiene derivatives of formula (I): <CHEM>  wherein: The symbols  @  @ ,  @  @  @ , Y, R and R<1> have the meaning indicated in the description, a process for their preparation and pharmaceutical compositions containing same.
Patent DK-0570192-T3 (DK)
Inventor: FARNWORTH MICHAEL ADRIAN
IPC: A45F3/04
Filed: 1993-05-11
Granted: 1998-03-30
Abstract: A hip pad and/or hip belt typically for use with a rucksack is disclosed. The hip pad includes an elongate foamed plastics element (10) to one surface of which a web (12) of stiff plastics material is mounted, which is characterised by additional reinforcement (14) in the form of a plurality of protrusions (18) and intervening grooves (20) provided in or on the web, with the grooves extending in a direction transversely to the longitudinal extent of the pad. Thus, in use, the grooves extend in a direction from the top to the bottom of the pad. The provision of such additional reinforcement protrusions facilitates an improved transmission of load to the pelvis of the wearer, whilst the transfer grooves permit the belt to still maintain a sufficient degree of flexibility in the longitudinal direction to allow it to be shaped to the body of the wearer. The load is thus spread more effectively and the overall weight of the hip pad may be reduced. Additionally a hip belt is described which comprises a pair of hip pads as aforementioned, with each hip pad having an enlarged region which in use lies adjacent the lumbar region of the wearer. <IMAGE>
Patent DK-0667625-T3 (DK)
Inventor: BAQUE THOMAS
IPC: C08L77/00
Filed: 1994-02-09
Granted: 1997-10-27
Abstract: Polyamide material (I) suitable for electrostatic coating, which consists of a mixt. contg. polyamide-6 (PA-6) or polyamide-6,6 (PA-66) and additives, is used for non-metallic mouldings or mouldings of metallic and non-metallic elements. (I) contains a metal powder and C fibres in the ratio (150:6):1. Also claimed are mouldings made from (I) and moulding prodn..
Patent DK-0623575-T3 (DK)
Inventor: BRAUN MAX DR
IPC: C07B61/00
Filed: 1994-04-19
Granted: 1999-07-26
Abstract: Described is a novel process for the preparation of ketones, for example CF3C(O)CH3, CF3C(O)CH2C(O)CF3 and CF3C(O)CF2H. In this process, ss-keto esters are transesterified and decarboxylated with a carboxylic acid, for example trifluoroacetic acid, in the presence of a catalyst, in particular an "onium" salt of a carboxylic acid or an effective amount of a proton-liberating acid, preferably a sulphonic acid such as alkyl- or arylsulphonic acids, or a mineral acid. It is expedient to carry out the process under anhydrous conditions. Therefore, no acetals or hydrates are formed, so that a dehydration step can be dispensed with. A further advantage of the process is the simple procedure. If a sufficiently active carboxylic acid is used for the transesterification reaction, for example trifluoroacetic acid, the presence of an additional catalyst is not required.
Patent DK-0627784-T3 (DK)
Inventor: JANKOWSKI MEINRAD
IPC: H01R13/115
Filed: 1992-04-13
Granted: 1997-10-06
Abstract: The socket is used for the connection of flat contact pins as are used in plug connecting devices for test purposes, especially in car construction. The socket (1), which allows frequent plug-in cycles with low insertion forces, comprises a contact spring support having two supporting walls (2, 3) which are essentially parallel to one another. Said walls (2, 3) are fitted, preferably on both inner sides, in each case with one row of contact springs (4) which are domed in such a manner that a gap (5) is formed by the domes which point towards one another, which gap (5) expands elastically when a flat contact pin is inserted, thus making contact. The ends (6, 7) of each contact spring (4) are bent around towards one another on the outside of the associated supporting wall (2, 3). The two supporting walls (2, 3) are connected to one another via a lateral wall (12) which determines the distance between them. A bearing wall (14) which bounds the insertion gap (5) for the flat contact pins is provided on the edges (13) of the supporting walls (2, 3) which are placed on the lateral wall (12). 
<IMAGE>
Patent DK-0646566-T3 (DK)
Inventor: BULL MICHAEL JOHN
IPC: C07C68/00
Filed: 1994-09-30
Granted: 1997-12-22
Abstract: A process for preparing a compound of general formula <CHEM> where Ar represents an optionally substituted aromatic or heteroaromatic group, the process comprising reacting a compound of general formula Ar-C(L<l>)2Cl   (II) where each L<l> independently represents a leaving group (preferably a chlorine atom), with water in the presence of a Lewis acid and a chlorocarbon solvent which includes at least two chlorine atoms, is disclosed.
Patent DK-0681757-T3 (DK)
Inventor: SCHROETTER JOHANNES
IPC: H02K49/10
Filed: 1994-01-27
Granted: 1996-08-05
Abstract: A magnetic force-transmitting device has at least two substantially roller-shaped bodies (12, 14) rotatively mounted next to each other. Magnetic spirals (18, 20) are arranged in the circumferential area of the rollers in such a way that like poles point outwards.
Patent DK-0652022-T3 (DK)
Inventor: MAKINO YUJI
IPC: A61M13/00
Filed: 1994-05-12
Granted: 1999-09-13
Abstract: A device for dispensing powdered medicine in multiple doses capable of spraying powdered medicine in a fixed amount and in multiple doses having a device main body (1), a storage chamber (3) detachably mounted on said main body for storing as much powdered medicine as can handle multiple doses, and an accomodation chamber (10) having a capacity for a single dose, wherein in order to enable powdered medicine inside said accomodation chamber (10) to be dispensed by causing said accomodation chamber to communicate with said storage chamber at a loading position (3a) and causing said accomodation chamber to communicate with the external portion of said main device at a dispensing position (5a) there are provided rotor (6) movably mounted on said main body for dispensing a fixed amount of powdered medicine, a cap (20) for moving said rotor between said loading position and said dispensing position and a pump (8) for injecting air at said loading position into said storage chamber via said accommodation chamber so as to stir powdered medicine in said storage chamber, whereby a fixed amount of powdered medicine after stirred is loaded into said accommodation chamber from said storage chamber by virtue of a suction force by said pump means and/or its own gravity. <IMAGE>
Patent DK-0752838-T3 (DK)
Inventor: ELSOHLY MAHMOUD A
IPC: A61K9/02
Filed: 1994-05-17
Granted: 2003-08-11
Abstract: Suppository formulations having long-term stability and containing readily bioavailable  DELTA 9-THC derivatives.
Patent DK-0703819-T3 (DK)
Inventor: TSE TANG MAN-WING
IPC: B01D69/12
Filed: 1994-06-03
Granted: 1998-06-02
Abstract: A composite membrane made of an asymmetric porous support and an ultrathin layer having a thickness of less than 100 nm is provided. A method of making the membrane and method for carrying out gas separations using the membrane are also provided.
Patent DK-0725776-T3 (DK)
Inventor: KANE JOHN M
IPC: A61P25/28
Filed: 1994-10-04
Granted: 1997-09-01
Abstract: This invention relates to the enhancement of memory and cognition and the treatment of Alzheimer's disease and Wernicke-Korsakoff syndrome by administration of 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles of formula (I) wherein R1 and R2 independently represent hydrogen, halogen, trifluoromethyl, nitro, C1-4 lower alkyl or C1-4 lower alkoxy, or together, R1 and R2 represent -CH=CH-CH=CH-, forming a 1- or 2-naphthylenyl ring system; R3 represents hydrogen or C1-4 lower alkyl; and R4 represents C1-4 lower alkyl, benzyl, or benzyl substituted by one or two groups selected from halogen, trifluoromethyl, nitro, C1-4 lower alkyl or C1-4 lower alkoxy.
Patent DK-0682866-T3 (DK)
Inventor: MUELLER JACKI
IPC: C09K23/14
Filed: 1995-05-05
Granted: 2000-04-03
Abstract: Aq. suspension concentrate contains pirimicarb and stabilising component(s). The concentrate may also contain formulation adjuvants as well as bactericides and/or other insecticides and conveniently has a pH of 6-8 (pref. 6-7.5). Pref. concentrate is typically has a water content of 1-700 g/l and contains as the stabilising component(s) a powdered stone e.g. calcite, talc, kaolinite, montmorillonite or attapulgite, and/or a synthetic silicic acid and/or a water-soluble intensive dye esp. one which is blue in colour.
Patent DK-0732928-T3 (DK)
Inventor: MAO SIMON J T
IPC: A61P3/10
Filed: 1994-11-03
Granted: 2005-04-18
Abstract: The use of a compound of formula (1) <CHEM> wherein: R1, R2, R3 and R4 are each independently a C1-C6 alkyl group; Z is a thio, oxy or methylene group; A is a C1-C4 alkylene group; and R5 is a C1-C6 alkyl or -(CH2)n-(Ar) wherein n is an integer 0, 1, 2 or 3; and Ar is phenyl or napthyl unsubstituted or substituted with one to three substituents selected from hydroxy, methoxy, ethoxy, chloro, fluoro or C1-C6 alkyl group for preparing a pharmaceutical for treating diabetes mellitus.
Patent DK-0758889-T3 (DK)
Inventor: STROPPOLO FEDERICO
IPC: A61K31/19
Filed: 1995-05-26
Granted: 2000-11-27
Abstract: PCT No. PCT/EP95/02010 Sec. 371 Date Nov. 27, 1996 Sec. 102(e) Date Nov. 27, 1996 PCT Filed May 26, 1995 PCT Pub. No. WO95/35104 PCT Pub. Date Dec. 28, 1995The present invention relates to a solid pharmaceutical composition containing (S)-2-(4-isobutylphenyl) propionic acid as active ingredient and it relates to a solid pharmaceutical composition suitable for the preparation of pharmaceutical forms in tablets, sachets and capsules containing (S)-2-(4-isobutylphenyl)-propionic acid as active ingredient. This formulation in tablets contains (S)-Ibupropen, colloidal silica as disintegrating agent, microcrystalline cellulose as diluent and magnesium stearate as lubricant. Tablets are prepared by direct compression of the pharmaceutical composition object of the present invention and may be coated or filmed according to conventional techniques.
Patent DK-0775418-T3 (DK)
Inventor: RYAN JOHN O
IPC: G06F21/10
Filed: 1995-07-12
Granted: 2000-11-13
Abstract: A video recording platform prevents both analog and digital copying of copy protected material. The platform may input and output both analog and digital video signals. At said analog input, a detector detects conventional copy protection in the analog input video, and in response disables recording thereof. At the digital input, a first detector detects a copyright signature present in the input material and in response prevents recording. A specially adapted video recorder, playback device or set top decoder copy protects video source material which has a copyright signature. A copyright signature is provided in a predetermined location in said video signal to be protected. The video recorder, playback device, or set top decoder upon detection of the copyright signature on its input or at playback, modifies the output standard (NTSC) video signal with a conventional copy protection process and the digital output with a new copyright signature. The input digital signal may contain a scrambling of the digital video signal in addition to the copy protection signature. In addition, an authenticating signature may be added to the digital video signal and detected as part of the copy protection process. As part of the copy protection, a television receiver includes a copy protection and descrambling system.
Patent DK-0780374-T3 (DK)
Inventor: TROGLIA CLAUDIO
IPC: C07C409/24
Filed: 1996-12-18
Granted: 2002-07-29
Abstract: Process for reducing the content of water in imido-alkanpercarboxylic acids comprising heating a suspension of imido-alkanpercarboxylc acid in water up to the complete solid melting and subsequent separation of the organic phase from the aqueous phase and recovery of the organic phase containing the imido-alkanpercarboxylic acid.
Patent DK-0721782-T3 (DK)
Inventor: ROBERTS MARK
IPC: A61K39/39
Filed: 1996-01-09
Granted: 2000-12-18
Abstract: The invention provides a vaccine composition comprising an effective immunogenic amount of an influenza antigen and an effective adjuvant amount of a non-toxic mutant form of pertussis toxin. The influenza antigen preferably comprises haemagglutinin and neuraminidase antigens, and in particular purified haemagglutinin and neuraminidase antigens. The non-toxic mutant form of pertussis toxin may be one in which the Glu 129 amino acid in the S1 sub-unit has been substituted by another amino acid, for example by glycine, and the arginine 9 amino acid residue has been substituted by another amino acid, for example by lysine. <IMAGE>   <IMAGE>